Ultragenyx Pharmaceutical Inc. Insider Trading for May 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for May 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Option Exercise | A | 68.59 | 10,000 | 685,900 | 10,000 | |
| May 27 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Grant | A | 0.00 | 5,000 | 0 | 9,334 | 4.3 K to 9.3 K (+115.37 %) |
| May 26 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Sell | S | 66.00 | 650 | 42,900 | 7,111 | 7.8 K to 7.1 K (-8.38 %) |
| May 24 2016 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & Senior Vice P ... | Payment of Exercise | F | 64.01 | 414 | 26,500 | 69,790 | 70.2 K to 69.8 K (-0.59 %) |
| May 24 2016 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | Controller and PAO | Payment of Exercise | F | 64.01 | 166 | 10,626 | 4,334 | 4.5 K to 4.3 K (-3.69 %) |
| May 24 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Payment of Exercise | F | 64.01 | 1,072 | 68,619 | 516,447 | 517.5 K to 516.4 K (-0.21 %) |
| May 24 2016 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Senior Vice P ... | Payment of Exercise | F | 64.01 | 414 | 26,500 | 41,387 | 41.8 K to 41.4 K (-0.99 %) |
| May 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 64.01 | 414 | 26,500 | 7,761 | 8.2 K to 7.8 K (-5.06 %) |
| May 23 2016 | RARE | Ultragenyx Pharmac ... | AGARWAL SUNIL | Chief Medical Offic ... | Payment of Exercise | F | 61.46 | 392 | 24,092 | 8,175 | 8.6 K to 8.2 K (-4.58 %) |
| May 18 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 61.93 | 200 | 12,386 | 517,519 | 517.7 K to 517.5 K (-0.04 %) |
| May 18 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 61.34 | 2,595 | 159,177 | 517,719 | 520.3 K to 517.7 K (-0.50 %) |
| May 18 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 60.32 | 6,390 | 385,445 | 520,314 | 526.7 K to 520.3 K (-1.21 %) |
| May 18 2016 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Sell | S | 59.37 | 10,815 | 642,087 | 526,704 | 537.5 K to 526.7 K (-2.01 %) |
| May 09 2016 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | SVP and Chief Tech ... | Payment of Exercise | F | 62.45 | 705 | 44,027 | 6,795 | 7.5 K to 6.8 K (-9.40 %) |